MasTec shares declined roughly 21.2% over the last 30 days, falling from $272.07 on August 19, 2026, to a latest close of $214.38. The pullback extends a broader slide, with the stock down more than 40% over the trailing three-month period.
Edison International (EIX) shares declined roughly 22.7% over the last 30 days, closing near $55.31 as of September 18, 2026, compared with about $71.59 a month earlier. The selloff was driven by California lawmakers rejecting Governor Gavin Newsom's proposal to limit utility wildfire liability, preserving insurers' right to seek recovery from utilities.
Casey's General Stores (CASY) shares fell roughly 28.5% over the past 30 days, dropping from about $835 to near $597. The decline was triggered by the company's fiscal first-quarter 2027 report, which beat estimates but left full-year guidance unchanged.
PG&E shares fell roughly 25% in 30 days, sliding from a closing price of $17.65 on Aug. 19 to $13.20 on Sept. 18. The selloff was triggered by California's amended wildfire legislation (SB 492), which left utilities without the liability protections investors had expected.
Twist Bioscience (TWST) rose roughly 15% over the trailing 30 days, climbing from about $145 in late August to $166.99 at the September 18 close. The rally accelerated after Twist announced a data-services agreement with Eli Lilly's ( LLY ) AI-driven TuneLab platform, sending shares up more than 31% in a single week.
GameStop Corp. (NYSE: GME ) trades near the low $20s, and the $40 level represents roughly 75% upside — a widely discussed price objective grounded in at least one published analyst target. The strongest bullish factors are a roughly $9 billion cash war chest, a return to consistent profitability, and CEO Ryan Cohen's ambitious acquisition strategy aimed at transforming the company.
The target: The $25 level sits roughly 25% above XP's recent price near $20 and aligns with several Wall Street price objectives, including UBS's $25 target. Bullish case: A "Strong Buy" consensus, a discounted valuation, heavy capital returns, and record asset gathering support the path higher.
Axon Enterprise shares declined roughly 30.7% over the past 30 days, from a closing price of $645.72 on August 19, 2026, to $447.76 on September 18, 2026. The selloff followed a strong Q2 2026 earnings report, as investors focused instead on contracting margins, expiring tariff credits, and the removal of cash-flow guidance.
Booking Holdings (BKNG) shares declined roughly 20% over the last 30 days, sliding from a close of $209.62 on August 21, 2026, to $167.90 at the September 18, 2026 close. The selloff was driven primarily by a European court ruling upholding the block of its $1.9 billion ETraveli acquisition and renewed investor anxiety over AI-driven disruption in online travel.
First Trust Nasdaq Semiconductor ETF (FTXL) employs a factor-based smart beta approach that selects and weights semiconductor stocks using liquidity, value, volatility, and growth metrics, resulting in approximately 35 holdings and an expense ratio of 0.60%. iShares Semiconductor ETF (SOXX) follows a market-capitalization-weighted methodology with concentration caps, tracking the NYSE Semiconductor Index with 30 holdings and a lower expense ratio of 0.35%.
SPCH is a single-stock leveraged exchange-traded fund (ETF) that targets 200% of the daily return of SpaceX ( SPCX ). The fund advanced roughly 21% over the trailing 30 days, recovering from its early-August lows.
SPCH is the Leverage Shares 2X Long SPCX Daily ETF, a single-stock leveraged exchange-traded fund (ETF) that seeks to deliver 200% (2x) of the daily performance of Space Exploration Technologies Corp. (SpaceX) stock, which trades under the ticker SPCX . The fund is actively managed and uses derivatives, primarily total return swaps, rather than directly holding large amounts of SpaceX shares.
The iShares Semiconductor ETF (SOXX) recently traded near $527, putting a $700 price target roughly 33% above current levels. Wall Street consensus is bullish, with an average 12-month price target near $706 — remarkably close to the $700 level investors are watching.
Amcor shares fell about 11.7% over the trailing 30 days, slipping from roughly $47.45 in mid-August to $41.90 by mid-September. The decline followed a strong earnings-driven rally, suggesting profit-taking and a rotation out of packaging names after an extended run-up.
GameStop (GME) shares climbed roughly +24.3% over the last 30 days, from about $18.21 to approximately $22.64 as of the most recent close. The advance followed better-than-expected fiscal second-quarter results and record second-quarter operating income of $160.2 million.
Avidity Biosciences (RNA) shares fell approximately 34.7% over the trailing 30 days, declining from a closing price of $13.71 on August 19, 2026, to $8.95 on September 18, 2026. The move was driven primarily by a September 8 setback for del-desiran, the lead antibody-oligonucleotide conjugate (AOC) candidate built on Avidity's platform, which missed its primary endpoint in the Phase III HARBOR study for myotonic dystrophy type 1 (DM1).
XP Inc. shares climbed roughly 21% over the trailing 30 days, rising from about $16.53 to $20.01. Second-quarter 2026 results beat estimates, showing strong client-asset growth and record net new money.
Both DINO and VLO are major U.S. oil and gas refining and marketing companies that have delivered substantial gains in recent market activity amid favorable refining conditions. DINO (HF Sinclair Corporation) operates seven refineries with approximately 678,000 barrels per day of crude throughput capacity and a market capitalization near $20.6 billion.
CCL and NCLH are leading cruise operators that have both faced notable price declines in recent market activity, driven by sector concerns including pricing pressures and fuel costs. CCL maintains a larger market capitalization of approximately $30 billion compared to NCLH ’s roughly $6.5 billion, with CCL offering a dividend yield while NCLH does not.
Joby Aviation (NYSE: JOBY) shares fell roughly 18.7% over the last 30 days, from a closing price near $7.53 to about $6.12. The decline extended a broader downtrend, with the stock down approximately 38.8% over the last quarter and more than 50% year to date.